Navigation Links
Hope For Stiff-Person Syndrome

At present, there is no cure for stiff-person syndrome, a disease marked by high levels of antibodies to glutamic acid decarboxylase (GAD65), an enzyme involved in the production of a movement-regulating neurotransmitter.// Patients are usually treated with Valium (diazepam), which is only mildly successful at controlling symptoms. While the cause of stiff-person syndrome is unknown, doctors had suspected that it may be an autoimmune disorder.

About 1 in every million people has the disorder, though it is often misdiagnosed and may be more common than recognized. Up to 65% of patients cannot perform daily tasks because of total-body stiffness or frequent falls. Some patients rely on walkers or wheelchairs while others are completely bedridden. Exposure to noise, touch or emotional distress can set off muscle spasms, and some patients are afraid to leave their house because of the spasms.

High doses of antibodies may help relieve the muscle rigidity and spasms associated with stiff-person syndrome. Patients who had infusions of immune globulin - a collection of antibodies derived from donor blood for 3 months were able to walk more easily, fell down less often, and reported improvements in their ability to perform work-related and household tasks.

The Findings indicate that intravenous immune globulin is safe, well tolerated, and effective for stiff-person syndrome and significantly improves patients' ability to perform the activities of daily living and thus, their quality of life. While the treatment had no major side effects, it is expensive, costing more than $10,000 a month.
'"/>




Page: 1

Related medicine news :

1. Early Clue to Down Syndrome
2. Restless Legs Syndrome - Help at hand
3. Severe Acute respiratory Syndrome (SARS)
4. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
5. Treatment for Syndrome X
6. “ Economy Class Syndrome
7. Dementia and Down Syndrome
8. Understanding Restless Legs Syndrome
9. A New Option for Patients Suffering From QT Syndrome
10. Individuals With Metabolic Syndrome At Risk of Dying From Heart Disease
11. The Link Between Pregnancy and Restless Legs Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: